$30.00
-0.15-0.5%
近くで: Sep 24, 5:00 PM EST
$27.92
-2.08-6.93%
時間外: Sep 14, 7:40 AM EST
Benzinga
Benzinga
Benzinga
木曜日, 9 24
Quince Therapeutics Inc
QNCXNASDAQ
Quince Therapeutics Earnings & Forecasts
Quince Therapeutics (QNCX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Quince Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-16.56 | $-37.40 | $-42.00 | $-42.00 |
| Actual | $-12.31 | $-90.00 | $-152.00 | $-50.00 |
| Surprise | +25.7% | -140.6% | -261.9% | -19.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.13 | $-1.03 |
| Revenue | ||
| Consensus | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved